Basic science and clinical application of platelet-rich plasma forcartilage defects and osteoarthritis: A review

Osteoarthritis and Cartilage

Volumn 21, Issue 11, 2013, Pages 1627-1637

  Zhu, Y ^a   Yuan, M ^a   Meng, H Y ^a   Wang, A Y ^a   Guo, Q Y ^a   Wang, Y ^a   Peng, J ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Cartilage defects; EGF; Osteoarthritis; Platelet rich plasma

Indexed keywords

GROWTH FACTOR;

ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE INJURY; CELL CULTURE; CELL DIFFERENTIATION; CENTRIFUGATION; HUMAN; IN VITRO STUDY; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; SCIENCE; THROMBOCYTE RICH PLASMA; TISSUE ENGINEERING; ANIMAL; CYTOLOGY; DISEASE MODEL; PROCEDURES; REGENERATION;

ANIMALS; CARTILAGE, ARTICULAR; CHONDROCYTES; DISEASE MODELS, ANIMAL; HUMANS; OSTEOARTHRITIS; PLATELET-RICH PLASMA; REGENERATION; TISSUE ENGINEERING;

EID: 84884936717     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2013.07.017     Document Type: Review

References (86)

1. Flanigan D.C., Harris J.D., Trinh T.Q., Siston R.A., Brophy R.H. Prevalence of chondral defects in athletes' knees-a systematic review. Med Sci Sports Exerc 2010, 42:1795-1801.
2. Erggelet C., Kreuz P.C., Mrosek E.H. Autologous chondrocyte implantation versus ACI using 3Dbioresorbable graft for the treatment of large full-thickness cartilage lesions of the knee. Arch Orthop Trauma Surg 2009, 1-8.
3. Jones E.A., Kinsey S.E., English A., Jones R.A., Straszynski L., Meredith D.M., et al. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 2002, 46:3349-3360.
4. Dohan Ehrenfest M.David, Rasmusson Lars, Albrektsson Tomas Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 2009, 27:158-167.
5. Schulz V., Kochsiek K., Kostering H., Ch Walther The preparation of platelet-rich plasma for platelet counts and tests of platelet function (author's transl). ZKlin Chem Klin Biochem 1971, 9:324-328.
6. Kutlu B., Tigli Aydin R.S., Akman A.C., Gumusderelioglu M., Nohutcu R.M. Platelet-rich plasma-loaded chitosan scaffolds: preparation and growth factor release kinetics. JBiomed Mater Res B Appl Biomater 2012, 101B.
7. Luengo Gimeno F., Gatto S., Ferro J., Croxatto J.O., Gallo J.E. Preparation of platelet-rich plasma as a tissue adhesive for experimental transplantation in rabbits. Thromb J 2006, 4:18.
8. Qureshi Amir H., Chaoji Vineet, Maiguel Dony, Faridi Mohd Hafeez, Barth Constantinos J., Salem Saeed M., et al. Proteomic and phospho-proteomic profile of human platelets in Basal, resting state: insights into integrin signaling. PLoS One 2009, 4:e7627.
9. Pietrzak W.S., Eppley B.L. Platelet rich plasma: biology and new technology. JCraniofac Surg 2005, 16:1043-1054.
10. Stiles C.D. The molecular biology of platelet-derived growth factor. Cell 1983, 33:653-655.
11. Weiser L., Bhargava M., Attia E., Torzilli P.A. Effect of serum and platelet-derived growth factor on chondrocytes grown in collagen gels. Tissue Eng 1999, 5:533-544.
12. Gaissmaier C., Koh J.L., Weise K. Growth and differentiation factors for cartilage healing and repair. Injury 2008, 39(Suppl 1):S88-S96.
13. Re'em T., Kaminer-Israeli Y., Ruvinov E., Cohen S. Chondrogenesis of hMSC in affinity-bound TGF-beta scaffolds. Biomaterials 2012, 33:751-761.
14. van der Kraan P.M., Goumans M.J., Blaney Davidson E., ten Dijke P. Age-dependent alteration of TGF-beta signalling in osteoarthritis. Cell Tissue Res 2012, 347:257-265.
15. Narcisi R., Quarto R., Ulivi V., Muraglia A., Molfetta L., Giannoni P. TGF beta-1 administration during exvivo expansion of human articular chondrocytes in a serum-free medium redirects the cell phenotype toward hypertrophy. JCell Physiol 2012, 227:3282-3290.
16. Yuan T., Guo S.C., Han P., Zhang C.Q., Zeng B.F. Applications of leukocyte- and platelet-rich plasma (L-PRP) in trauma surgery. Curr Pharm Biotechnol 2012, 13:1173-1184.
17. Gaissmaier C., Fritz J., Krackhardt T., Flesch I., Aicher W.K., Ashammakhi N. Effect of human platelet supernatant on proliferation and matrix synthesis of human articular chondrocytes in monolayer and three-dimensional alginate cultures. Biomaterials 2005, 26:1953-1960.
18. Kaps C., Loch A., Haisch A., Smolian H., Burmester G.R., Haiupl T., et al. Human platelet supernatant promotes proliferation but not differentiation of articular chondrocytes. Med Biol Eng Comput 2002, 40:5.
19. Chen F.H., Tuan R.S. Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther 2008, 10:223.
20. Bernardo M.E., Avanzini M.A., Perotti C., Cometa A.M., Moretta A., Lenta E., et al. Optimization of invitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. JCell Physiol 2007, 211:121-130.
21. Zhao Y., Zhai W. Histological observation of tendon-bone healing after anterior cruciate ligament reconstruction by platelet-rich plasma combined with deproteinized bone of calf. Zhongguo xiu fu chong jian wai ke za zhi=Zhongguo xiufu chongjian waike zazhi=Chin J Reparative Reconstr Surg 2010, 24:1323-1329.
22. Lucarelli E., Beccheroni A., Donati D., Sangiorgi L., Cenacchi A., Del Vento A.M., et al. Platelet-derived growth factors enhance proliferation of human stromal stem cells. Biomaterials 2003, 24:3095-3100.
23. Gotterbarm T., Richter W., Jung M., Berardi Vilei S., Mainil-Varlet P., Yamashita T., et al. An invivo study of a growth-factor enhanced, cell free, two-layered collagen-tricalcium phosphate in deep osteochondral defects. Biomaterials 2006, 27:3387-3395.
24. Mifune Y., Matsumoto T., Takayama K., Ota S., Li H., Meszaros L.B., et al. The effect of platelet-rich plasma on the regenerative therapy of muscle derived stem cells for articular cartilage repair. Osteoarthritis Cartilage/OARS Osteoarthritis Res Soc 2012, 21:175-185.
25. Guner S., Buyukbebeci O. Analyzing the effects of platelet gel on knee osteoarthritis in the rat model. Clin Appl Thromb/Hemost: Off J Int Acad Clin Appl Thromb/Hemost 2012.
26. Sun Y., Feng Y., Zhang C.Q., Chen S.B., Cheng X.G. The regenerative effect of platelet-rich plasma on healing in large osteochondral defects. Int Orthop 2010, 34:589-597.
27. Kwon D.R., Park G.Y., Lee S.U. The effects of intra-articular platelet-rich plasma injection according to the severity of collagenase-induced knee osteoarthritis in a rabbit model. Ann Rehabil Med 2012, 36:458-465.
28. Saito M., Takahashi K.A., Arai Y., Inoue A., Sakao K., Tonomura H., et al. Intraarticular administration of platelet-rich plasma with biodegradable gelatin hydrogel microspheres prevents osteoarthritis progression in the rabbit knee. Clin Exp Rheumatol 2009, 27:201-207.
29. Qi Y.Y., Chen X., Jiang Y.Z., Cai H.X., Wang L.L., Song X.H., et al. Local delivery of autologous platelet in collagen matrix simulated in situ articular cartilage repair. Cell Transplant 2009, 18:1161-1169.
30. Bielecki T.M., Gazdzik T.S., Arendt J., Szczepanski T., Krol W., Wielkoszynski T. Antibacterial effect of autologous platelet gelenriched with growth factors and other active substances: an invitro study. JBone Joint Surg. British Volume 2007, 89:417-420.
31. Milano G., Sanna Passino E., Deriu L., Careddu G., Manunta L., Manunta A., et al. The effect of platelet rich plasma combined with microfractures on the treatment of chondral defects: an experimental study in a sheep model. Osteoarthritis Cartilage/OARS Osteoarthritis Res Soc 2010, 18:971-980.
32. Xie X., Wang Y., Zhao C., Guo S., Liu S., Jia W., et al. Comparative evaluation of MSCs from bone marrow and adipose tissue seeded in PRP-derived scaffold for cartilage regeneration. Biomaterials 2012, 33:7008-7018.
33. Anitua E., Sanchez M., Nurden A.T., Zalduendo M.M., de la Fuente M., Azofra J., et al. Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts fromarthritic patients. Rheumatology (Oxford) 2007, 46:1769-1772.
34. Yamada Y., Ueda M., Naiki T., Takahashi M., Hata K., Nagasaka T. Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: tissue-engineered bone regeneration. Tissue Eng 2004, 10:955-964.
35. Kon E., Filardo G., Delcogliano M., Fini M., Salamanna F., Giavaresi G., et al. Platelet autologous growth factors decrease the osteochondral regeneration capability of a collagen-hydroxyapatite scaffold in a sheep model. BMC Musculoskelet Disord 2010, 11:220.
36. Anitua E., Sanchez M., Zalduendo M.M., de la Fuente M., Prado R., Orive G., et al. Fibroblastic response to treatment with different preparations rich in growth factors. Cell Prolif 2009, 42:162-170.
37. Kon E., Buda R., Filardo G., Di Martino A., Timoncini A., Cenacchi A., et al. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc Off J ESSKA 2010, 18:472-479.
38. Kon E., Mandelbaum B., Buda R., Filardo G., Delcogliano M., Timoncini A., et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy 2011, 27:1490-1501.
39. Filardo G., Kon E., Buda R., Timoncini A., Di Martino A., Cenacchi A., et al. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc Off J ESSKA 2011, 19:528-535.
40. Spakova T., Rosocha J., Lacko M., Harvanova D., Gharaibeh A. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil/Assoc Acad Physiatrists 2012.
41. Mei-Dan O., Carmont M.R., Laver L., Mann G., Maffulli N., Nyska M. Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med 2012, 40:534-541.
42. Sanchez M., Anitua E., Azofra J., Aguirre J.J., Andia I. Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retrospective cohort study. Clin Exp Rheumatol 2008, 26:910-913.
43. Filardo G., Kon E., Di Martino A., Di Matteo B., Merli M.L., Cenacchi A., et al. Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial. BMC Musculoskelet Disord 2012, 13:229.
44. Sampson S., Reed M., Silvers H., Meng M., Mandelbaum B. Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: a pilot study. Am J Phys Med Rehabil/Assoc Acad Physiatrists 2010, 89:961-969.
45. Siclari A., Mascaro G., Gentili C., Cancedda R., Boux E. Acell-free scaffold-based cartilage repair provides improved function hyaline-like repair at one year. Clin Orthop Relat Res 2012, 470:910-919.
46. Sanchez M., Azofra J., Anitua E., Andia I., Padilla S., Santisteban J., et al. Plasma rich in growth factors to treat an articular cartilage avulsion: a case report. Med Sci Sports Exerc 2003, 35:1648-1652.
47. Filardo G., Kon E., Pereira Ruiz M.T., Vaccaro F., Guitaldi R., Di Martino A., et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc Off J ESSKA 2012, 20:2082-2091.
48. Halpern B., Chaudhury S., Rodeo S.A., Hayter C., Bogner E., Potter H.G., et al. Clinical and MRI outcomes after platelet-rich plasma treatment for knee osteoarthritis. Clin J Sport Med Off J Can Acad Sport Med 2012, 23:238-239.
49. Haleem A.M., Singergy A.A., Sabry D., Atta H.M., Rashed L.A., Chu C.R., et al. The clinical use of human culture-expanded autologous bone marrow mesenchymal stem cells transplanted on platelet-rich fibrin glue in the treatment of articular cartilage defects: a pilot study and preliminary results. Cartilage 2010, 1:253-261.
50. Lee H.R., Park K.M., Joung Y.K., Park K.D., Do S.H. Platelet-rich plasma loaded hydrogel scaffold enhances chondrogenic differentiation and maturation with up-regulation of CB1 and CB2. JControlled Release: Off J Controlled Release Soc 2012, 159:332-337.
51. Giannini S., Buda R., Cavallo M., Ruffilli A., Cenacchi A., Cavallo C., et al. Cartilage repair evolution in post-traumatic osteochondral lesions of the talus: from open field autologous chondrocyte to bone-marrow-derived cells transplantation. Injury 2010, 41:1196-1203.
52. Woodall J., Tucci M., Mishra A., Benghuzzi H. Cellular effects of platelet rich plasma: a study on HL-60 macrophage-like cells. Biomed Sci Instrum 2007, 43:266-271.
53. Xiaofeng Jia, Peters Paul G., Schon Lew The use of platelet-rich plasma in the management of foot and ankle conditions. Oper Tech Sports Med 2011, 19:177-184.
54. Li M., Zhang C., Ai Z., Yuan T., Feng Y., Jia W. Therapeutic effectiveness of intra-knee-articular injection of platelet-rich plasma on knee articular cartilage degeneration. Zhongguo xiu fu chong jian wai ke za zhi=Zhongguo xiufu chongjian waike zazhi=Chin J Reparative Reconstr Surg 2011, 25:1192-1196.
55. Hao H., Chen G., Liu J., Ti D., Zhao Y., Xu S., et al. Culturing on Wharton's jelly extract delays mesenchymal stem cell senescence through p53 and p16INK4a/pRb pathways. PLoS One 2013, 8:e58314.
56. Dhillon R.S., Schwarz E.M., Maloney M.D. Platelet-rich plasma therapy - future or trend?. Arthritis Res Ther 2012, 14:219.
57. Nagai T., Sato M., Kutsuna T., Kokubo M., Ebihara G., Ohta N., et al. Intravenous administration of anti-vascular endothelial growth factor humanized monoclonal antibody bevacizumab improves articular cartilage repair. Arthritis Res Ther 2010, 12:R178.
58. DeLong J.M., Russell R.P., Mazzocca A.D. Platelet-rich plasma: the PAW classification system. Arthroscopy 2012, 28:998-1009.
59. Pettersson S., Wettero J., Tengvall P., Kratz G. Human articular chondrocytes on macroporous gelatin microcarriers form structurally stable constructs with blood-derived biological glues invitro. JTissue Eng Regen Med 2009, 3:450-460.
60. Akeda K., An H.S., Okuma M., Attawia M., Miyamoto K., Thonar E.J., et al. Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthritis Cartilage/OARS Osteoarthritis Res Soc 2006, 14:1272-1280.
61. Spreafico A., Chellini F., Frediani B., Bernardini G., Niccolini S., Serchi T., et al. Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes. JCell Biochem 2009, 108:1153-1165.
62. Park S.I., Lee H.R., Kim S., Ahn M.W., Do S.H. Time-sequential modulation in expression of growth factors from platelet-rich plasma (PRP) on the chondrocyte cultures. Mol Cell Biochem 2012, 361:9-17.
63. Mishra A., Tummala P., King A., Lee B., Kraus M., Tse V., et al. Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. Tissue Eng Part C, Methods 2009, 15:431-435.
64. Sanjay Gottipamula, Archana Sharma, Krishnamurthy Sagar, Majumdar Anish Sen, Seetharam Raviraja N. Human platelet lysate is an alternative to fetal bovine serum for large-scale expansion of bone marrow-derived mesenchymal stromal cells. Biotechnol Lett 2012, 34:1367-1374.
65. Ben Azouna N., Jenhani F., Regaya Z., Berraeis L., Ben Othman T., Ducrocq E., et al. Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum. Stem Cell Res Ther 2012, 3:6.
66. Schallmoser K., Bartmann C., Rohde E., Reinisch A., Kashofer K., Stadelmeyer E., et al. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 2007, 47:1436-1446.
67. Murphy M.B., Blashki D., Buchanan R.M., Yazdi I.K., Ferrari M., Simmons P.J., et al. Adult and umbilical cord blood-derived platelet-rich plasma for mesenchymal stem cell proliferation, chemotaxis, and cryo-preservation. Biomaterials 2012, 33:5308-5316.
68. Kruger J.P., Hondke S., Endres M., Pruss A., Siclari A., Kaps C. Human platelet-rich plasma stimulates migration and chondrogenic differentiation of human subchondral progenitor cells. JOrthop Res: Off Publ Orthop Res Soc 2012, 30:845-852.
69. Kocaoemer A., Kern S., Kluter H., Bieback K. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 2007, 25:1270-1278.
70. Duan J., Kuang W., Tan J., Li H., Zhang Y., Hirotaka K., et al. Differential effects of platelet rich plasma and washed platelets on the proliferation of mouse MSC cells. Mol Biol Rep 2011, 38:2485-2490.
71. Drengk A., Zapf A., Sturmer E.K., Sturmer K.M., Frosch K.H. Influence of platelet-rich plasma on chondrogenic differentiation and proliferation of chondrocytes and mesenchymal stem cells. Cells Tissues Organs 2009, 189:317-326.
72. Zaky S.H., Ottonello A., Strada P., Cancedda R., Mastrogiacomo M. Platelet lysate favours invitro expansion of human bone marrow stromal cells for bone and cartilage engineering. JTissue Eng Regen Med 2008, 2:472-481.
73. Wu W., Chen F., Liu Y., Ma Q., Mao T. Autologous injectable tissue-engineered cartilage by using platelet-rich plasma: experimental study in a rabbit model. JOral Maxillofac Surg 2007, 65:1951-1957.
74. Wang-Saegusa A., Cugat R., Ares O., Seijas R., Cusco X., Garcia-Balletbo M. Infiltration of plasma rich in growth factors for osteoarthritis of the knee short-term effects on function and quality of life. Arch Orthop Trauma Surg 2011, 131:311-317.
75. Baltzer A.W., Moser C., Jansen S.A., Krauspe R. Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthritis Cartilage 2009, 17:152-160.
76. Jang S.J., Kim J.D., Cha S.S. Platelet-rich plasma (PRP) injections as an effective treatment for early osteoarthritis. Eur J Orthop Surg Traumatol 2012, 23:573-580.
77. Sanchez M., Guadilla J., Fiz N., Andia I. Ultrasound-guided platelet-rich plasma injections for the treatment of osteoarthritis of the hip. Rheumatology 2012, 51:144-150.
78. Koh Y.G., Jo S.B., Kwon O.R., Suh D.S., Lee S.W., Park S.H., et al. Mesenchymal stem cell injections improve symptoms of knee osteoarthritis. Arthroscopy 2013, 29:1-8.
79. Napolitano M., Matera S., Bossio M., Crescibene A., Costabile E., Almolla J., et al. Autologous platelet gel for tissue regeneration in degenerative disorders of the knee. Blood Transfus=Trasfusione del sangue 2012, 10:72-77.
80. Gobbi A., Karnatzikos G., Mahajan V., Malchira S. Platelet-rich plasma treatment in symptomatic patients with knee osteoarthritis: preliminary results in a group of active patients. Sports Health 2012, 4:162-172.
81. Dhollander A.A., De Neve F., Almqvist K.F., Verdonk R., Lambrecht S., Elewaut D., et al. Autologous matrix-induced chondrogenesis combined with platelet-rich plasma gel: technical description and a five pilot patients report. Knee Surg Sports Traumatol Arthrosc Off J ESSKA 2011, 19:536-542.
82. Giannini S., Buda R., Battaglia M., Cavallo M., Ruffilli A., Ramponi L., et al. One-step repair in talar osteochondral lesions: 4-year clinical results and t2-mapping capability in outcome prediction. Am J Sports Med 2013, 41:511-518.
83. Giannini S., Buda R., Vannini F., Cavallo M., Grigolo B. One-step bone marrow-derived cell transplantation in talar osteochondral lesions. Clin Orthop Relat Res 2009, 467:3307-3320.
84. Battaglia M., Rimondi E., Monti C., Guaraldi F., Sant'Andrea A., Buda R., et al. Validity of T2 mapping in characterization of the regeneration tissue by bone marrow derived cell transplantation in osteochondral lesions of the ankle. Eur J Radiol 2011, 80:e132-e139.
85. Patel S., Dhillon M.S., Aggarwal S., Marwaha N., Jain A. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med 2013, 41:356-364.
86. Pallua N., Wolter T., Markowicz M. Platelet-rich plasma in burns. Burns 2010, 36:4-8.